IDiyas

For the Inventor, By the Inventor

Brugherio, Italy

Anna Vulpetti

USPTO Granted Patents = 20



Average Co-Inventor Count = 7.5

ph-index = 8

Forward Citations = 390(Granted Patents)


Location History:

  • Brugherio, IT (2000 - 2014)
  • Milan, IT (1998 - 2019)

Company Filing History:

goldMedal10 out of 138 
 
Nerviano Medical Sciences S.r.l.
 patents
silverMedal5 out of 97 
 
Pharmacia & Upjohn S.p.a.
 patents
bronzeMedal3 out of 23 
 
Pfizer Italia S.r.l.
 patents
4. 2 out of 26 
 
Pharmacia Italia S.p.a.
 patents

Years Active: 1998-2019

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents
1. 10280176 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2019-05-07),
2. 9637497 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2017-05-02),
3. 9464090 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2016-10-11),
4. 8981089 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2015-03-17),
5. 8785448 - Substituted pyrrolo-pyrazole derivatives as kinase inhibitors (2014-07-22),
6. 8557857 - Substituted pyrrolo-pyrazole derivatives as kinase inhibitors (2013-10-15),
7. 8557845 - Substituted pyrrolo-pyrazole derivatives as kinase inhibitors (2013-10-15),
8. 8541429 - Pyrazolo quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2013-09-24),
9. 8481585 - Substituted pyrrolo-pyrazole derivatives as kinase inhibitors (2013-07-09),
10. 7511136 - Aminoindazole derivatives active as kinase inhibitors (2009-03-31),
11. 7482354 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2009-01-27),
12. 7407971 - Substituted pyrrolo-pyrazole derivatives as kinase inhibitors (2008-08-05),
13. 7105535 - Oxazolyl-pyrazole derivatives as kinase inhibitors (2006-09-12),
14. 7037929 - 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents (2006-05-02),
15. 6863647 - 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents (2005-03-08),

Title: Anna Vulpetti: Innovator in Kinase Inhibitors

Introduction

Anna Vulpetti, based in Brugherio, Italy, is a prominent inventor with a significant contribution to the field of pharmaceutical sciences. With 20 patents to her name, she has demonstrated a remarkable ability to innovate and develop new therapeutic compounds.

Latest Patents

Among her latest patents are the Pyrazolo-quinazoline derivatives, which are processes for their preparation and their applications as kinase inhibitors. These derivatives, represented by formulas (Ia) and (Ib), include pharmaceutically acceptable salts and aim to provide therapeutic solutions for diseases linked to misguided protein kinase activities, such as cancer. These innovations show promise in offering new treatment avenues for affected patients.

Career Highlights

Anna has made significant strides in her career, working with renowned companies such as Nerviano Medical Sciences S.r.l. and Pharmacia & Upjohn S.p.a. Her expertise in the development of therapeutic agents has been instrumental in advancing medical science, particularly in oncology.

Collaborations

Throughout her career, Anna has collaborated with notable colleagues including Paolo Pevarello and Maria Gabriella Brasca. These partnerships have enriched her research and contributed to her success in the pharmaceutical sector.

Conclusion

Anna Vulpetti exemplifies the innovative spirit necessary to drive advancements in pharmaceutical research. Her contributions, particularly in the area of kinase inhibitors, are paving the way for new treatments that may significantly impact patient care in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…